Forcing tumor cells to get with the re-program BioWorld News #preclinical
BioWorld News
Media and Telecommunications
Actionable intelligence on the most innovative therapeutics and medical technologies in development
About us
BioWorld’s suite of news services delivers actionable intelligence on the most innovative therapeutics and medical technologies in development. With writers and editors stationed around the globe, BioWorld reports the breaking news – and provides key perspective on hundreds of therapeutics and devices in development, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes. BioWorld The flagship daily biopharmaceutical news source covers the complete lifecycle of thousands of therapies in development from around the world, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes. Includes data-rich content focused on financial and strategic trends with deep analysis that helps decision makers develop dynamic strategies. BioWorld MedTech The news source of record covering the latest advances in medical technologies from around the world ranging from actual devices, such as orthopedic implants, to digital health tools. BioWorld Science News and analysis on discovery and preclinical research to support crucial drug R&D decisions at the earliest stages. BioWorld Asia The weekly monitor of biopharmaceutical developments in the Asia-Pacific region
- Website
-
https://www.bioworld.com/
External link for BioWorld News
- Industry
- Media and Telecommunications
- Company size
- 11-50 employees
- Type
- Public Company
- Founded
- 1990
Updates
-
First in a decade: FDA clears Adaptimmune T-cell therapy Tecelra #biotech #pharma
First in a decade: FDA clears Adaptimmune T-cell therapy Tecelra
bioworld.com
-
Synchron links brain implant device to Apple Vision Pro #medtech #synchroninc #neuralimplant
Synchron links brain implant device to Apple Vision Pro
bioworld.com
-
Removing CD5 'brake' on CAR T cells increases antitumor efficacy BioWorld News #preclinical
Removing CD5 'brake' on CAR T cells increases antitumor efficacy
bioworld.com
-
Esperto uses ultrasound to uncuff blood pressure measurement #medtech #Hypertension
Esperto uses ultrasound to uncuff blood pressure measurement
bioworld.com
-
Mutated tumor suppressors may become oncogenes, potential drug targets BioWorld News #preclinical
Mutated tumor suppressors may become oncogenes, potential drug targets
bioworld.com
-
Noze secures another $5M to develop breath-based diagnostic #medtech #Noze #Breathanalyzer #Breathomics #BreatheBiomedicalInc #OwlstoneMedical
Noze secures another $5M to develop breath-based diagnostic
bioworld.com
-
Ensho debuts to target gut inflammation with oral α4β7 inhibitors BioWorld News #preclinical
Ensho debuts to target gut inflammation with oral α4β7 inhibitors
bioworld.com